Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis

Bioanalysis

Volumn 1, Issue 4, 2009, Pages 847-855

  Chiu, Chi Li ^a   Randall, Sarah ^a   Molloy, Mark P ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN;

AFFINITY CHROMATOGRAPHY; ANALYSIS; BLOOD; HUMAN; LIMIT OF DETECTION; MASS SPECTROMETRY; METHODOLOGY; PROTEOMICS; REVIEW;

ANALYTIC SAMPLE PREPARATION METHODS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, AFFINITY; HUMANS; LIMIT OF DETECTION; MASS SPECTROMETRY; PROTEOMICS;

EID: 77952408229     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.56     Document Type: Review

References (41)

1. Anderson NL anderson NG. The human plasma proteome: history, character and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867 (2002).
2. Putnam F. The Plasma Proteins: Structure, Function and Genetic Control. Academic Press, NY, USA (1987).
3. Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol. 563, 23-60 (2005).
4. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 5, 573-588 (2006).
5. Omenn GS. Strategies for plasma proteomic profling of cancers. Proteomics 6, 5662-5673 (2006).
6. Hortin GL, Sviridov D, Anderson NL. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 54, 1608-1616 (2008).
7. Rai AJ, Gelfand CA, Haywood BC et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262-3277 (2005).
8. Rai AJ, Vitzthum F. Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics. Expert Rev. Proteomics 3, 409-426 (2006).
9. Dass C. Principles and Practice of Biological Mass Spectrometry (Wiley-Interscience Series on Mass Spectrometry). Desiderio DM, Nibbering NMM (Eds). John Wiley & Sons, NY, USA (2001).
10. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 422, 198-207 (2003).
11. Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1, 252-262 (2005).
12. Sherman J, McKay MJ, Ashman K, Molloy MP. How specifc is my SRM? The issue of precursor and product ion redundancy. Proteomics 9, 1120-1123 (2009).
13. Echan LA, Tang HY, Ali-Khan N, Lee K, Speicher DW. Depletion of multiple high-abundance proteins improves protein profling capacities of human serum and plasma. Proteomics 5, 3292-3303 (2005).
14. Qian WJ, Kaleta DT, Petritis BO et al. Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffnity separation strategy. Mol. Cell. Proteomics 7, 1963-1973 (2008).
15. Keshishia, H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 6, 2212-2229 (2007).
16. Meza J, Hunter C. Intelligent use of retention time for higher order multiple reaction monitoring multiplexing-scheduled MRM™ algorithm. Presented at: 56th American Society for Mass Spectrometry. CO, USA 1-5 June 2008.
17. Domon B, Aebersold R. Mass spectrometry and protein ana lysis. Science 312, 212-217 (2006).
18. Plavina T, Wakshull E, Hancock WS, Hincapie M. Combination of abundant protein depletion and multi-lectin affnity chromatography (M-LAC) for plasma protein biomarker discovery. J. Proteome Res. 6, 662-671 (2007).
19. Stahl-Zeng J, Lange V, Ossola R et al. High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol. Cell. Proteomics 6, 1809-1817 (2007).
20. Berna M, Ott L, Engle S, Watson D, Solter P, Ackermann B. Quantifcation of NTproBNP in rat serum using immunoprecipitation and LC/MS/MS: a biomarker of drug-induced cardiac hypertrophy. Anal. Chem. 80, 561-566 (2008).
21. Sen JW, Bergen HR 3rd, Heegaard NH. On-line immunoaffnity-liquid chromatography-mass spectrometry for identifcation of amyloid disease markers in biological fuids. Anal. Chem. 75, 1196-1202 (2003).
22. Berna MJ, Zhen Y, Watson DE, Hale JE, Ackermann BL. Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantifcation: myosin light chain 1, a biomarker of cardiac necrosis. Anal. Chem. 79, 4199-4205 (2007).
23. Nicol GR, Han M, Kim J et al. Use of an immunoaffnity-mass spectrometry-based approach for the quantifcation of protein biomarkers from serum samples of lung cancer patients. Mol. Cell. Proteomics 7, 1974-1982 (2008).
24. Barr JR, Maggio VL, Patterson DG Jr et al. Isotope dilution-mass spectrometric quantifcation of specifc proteins: model application with apolipoprotein A-I. Clin. Chem. 42, 1676-1682 (1996).
25. 13C-labeled peptide standards. Proteomics 4, 1175-1186 (2004).
26. McKay M, Sherman J, Laver M, Baker M, Clarke S, Molloy M. The development of multiple reaction monitoring assays for liver-derived plasma proteins. Proteomics Clin. Appl. 1, 1570-1581 (2007).
27. Lestin M, Hergert M, Lestin HG et al. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems. Clin. Lab. 48, 211-221 (2002).
28. Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG. LC-MS/MS quantifcation of Zn-a2 glycoprotein: a potential serum biomarker for prostate cancer. Clin. Chem. 53(4), 673-678 (2007)
29. deWilde A, Sadilkova K, Sadilek M, Vasta V, Hahn SH. Tryptic peptide ana lysis of ceruloplasmin in dried blood spots using liquid chromatography-tandem mass spectrometry: application to newborn screening. Clin. Chem. 54, 1961-1968 (2008).
30. van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Liquid chromatography/tandem mass spectrometric method for the quantifcation of eight proteolytic fragments of ITIH4 with biomarker potential in human plasma and serum. Rapid Commun. Mass Spectrom. 22, 2915-2928 (2008).
31. Zhang Z, Bast RC Jr, Yu Y et al. Three biomarkers identifed from serum proteomic ana lysis for the detection of early stage ovarian cancer. Cancer Res. 64, 5882-5890 (2004).
32. Villanueva J, Shaffer DR, Philip J et al. Differential exoprotease activities confer tumor-specifc serum peptidome patterns. J. Clin. Invest. 116, 271-284 (2006).
33. Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J. Proteome Res. 3, 235-244 (2004).
34. Whiteaker JR, Zhao L, Zhang HY et al. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantifcation of serum biomarkers. Anal. Biochem. 362, 44-54 (2007).
35. Hoofnagle AN, Becker JO, Wener MH, Heinecke JW. Quantifcation of thyroglobulin, a low-abundance serum protein, by immunoaffnity peptide enrichment and tandem mass spectrometry. Clin. Chem. 54, 1796-1804 (2008).
36. Anderson N, Anderson N, Pearson TW et al. A human proteome detection and quantitation project: hPDQ Mol. Cell. Proteomics 8, 883-886 (2009).
37. Berglund L, Bjorling E, Oksvold P et al. A genecentric human protein atlas for expression profles based on antibodies. Mol. Cell. Proteomics 7, 2019-2027 (2008).
38. Kay RG, Gregory B, Grace PB, Pleasance S. The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum. Rapid Commun. Mass Spectrom. 21, 2585-2593 (2007).
39. Daniel YA, Turner C, Haynes RM, Hunt BJ, Dalton RN. Quantifcation of hemoglobin A2 by tandem mass spectrometry. Clin. Chem. 53, 1448-1454 (2007).
40. Becher F, Pruvost A, Clement G, Tabet JC, Ezan E. Quantifcation of small therapeutic proteins in plasma by liquid chromatography-tandem mass spectrometry: application to an elastase inhibitor EPI-hNE4. Anal. Chem. 78, 2306-2313 (2006).
41. Kirsch S, Widart J, Louette J, Focant JF, De Pauw E. Development of an absolute quantifcation method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry. J. Chromatogr. A 1153, 300-306 (2007).